N. J. O’Higgins

Pooled Analysis of Prognostic Impact of Urokinase-Type Plasminogen Activator and Its Inhibitor PAI-1 in 8377 Breast Cancer Patients

Maxime P. Look, Wim L.J. van Putten, Michael J. Duffy et al. · JNCI Journal of the National Cancer Institute · 2002 · 600 citations · Full text

Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer.

Michael J. Duffy, David Reilly, Cathriona O'Sullivan et al. · PubMed · 1990 · 285 citations

Tumor Biology, Prognostic Biomarkers, Urology +14

Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer

M. Gershanovich, H.A. Chaudri, Diogo Ayres‐de‐Campos et al. · Annals of Oncology · 1998 · 263 citations · Full text

Advanced Breast Cancer, Breast Oncology, Oncology +11

Prognostic importance of survivin in breast cancer

Susan Kennedy, Lorraine O’Driscoll, Rachel Purcell et al. · British Journal of Cancer · 2003 · 253 citations · Full text

Nuclear Expression, Breast Oncology, Malignant Disease +9

Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer

Catherine Duggan, Teresa Maguire, E. McDermott et al. · International Journal of Cancer · 1995 · 150 citations